RNF112 and bladder transitional cell carcinoma: The inhibitory effects of RNF112 on the progression of malignant glioblastoma multiforme are attributed to its influence on p53‐mediated cell cycle regulation.[10] In gastric cancer, RNF112 interacts with FOXM1 through its N‐terminal structural domain and promotes its ubiquitination‐mediated degradation, ultimately inhibiting tumor growth and metastasis.[8] Nevertheless, there have been no reports on the expression and role of RNF112 in BLCA thus far.